Hudson Executive Capital LP

Average Profitability
<0.0001%
Insider Buys Quantity
10
Insider Buys Sum
$10.31M
Insider Sells Quantity
17
Insider Sells Sum
$5.46M

Insider Activity of Hudson Executive Capital LP

The largest purchase of all time was on 2019-08-01 and amounted to 1000252 shares of Cantaloupe, Inc. for $6.93M.

The largest sale of all time was on 2019-10-11 and amounted to 16300 shares of Eagle Pharmaceuticals, Inc. for $984,419.

Biography of Hudson Executive Capital LP

No biography is available at this moment.

2023-02-21SaleCantaloupe, Inc.
CTLP
10 percent owner
90,582
0.1337%
$6.30$570,667
2021-08-16PurchaseTalkspace, Inc.
TALK
10 percent owner
142,500
0.0929%
$5.30$755,250-67.6%
2021-08-13PurchaseTalkspace, Inc.
TALK
10 percent owner
46,000
0.03%
$5.23$240,580-67.11%
2021-08-12PurchaseTalkspace, Inc.
TALK
10 percent owner
2,100
0.0014%
$5.17$10,857-67.08%
2019-10-25SaleEagle Pharmaceuticals, Inc.
EGRX
director
15,437
0.1119%
$63.57$981,302-23.33%
2019-10-24SaleEagle Pharmaceuticals, Inc.
EGRX
director
1,494
0.0109%
$62.53$93,413-21.42%
2019-10-23SaleEagle Pharmaceuticals, Inc.
EGRX
director
200
0.0015%
$62.58$12,516-21.06%
2019-10-22SaleEagle Pharmaceuticals, Inc.
EGRX
director
6,567
0.048%
$62.68$411,618-21.14%
2019-10-21SaleEagle Pharmaceuticals, Inc.
EGRX
director
3,849
0.0281%
$62.56$240,791-20.9%
2019-10-18SaleEagle Pharmaceuticals, Inc.
EGRX
director
1,600
0.0118%
$62.61$100,174-19.82%
2019-10-17SaleEagle Pharmaceuticals, Inc.
EGRX
director
13,842
0.1007%
$62.58$866,196-20.8%
2019-10-16PurchaseCantaloupe, Inc.
CTLP
165,000
0.2579%
$7.26$1.2M-3.49%
2019-10-16SaleEagle Pharmaceuticals, Inc.
EGRX
director
102
0.0007%
$62.50$6,375-19.97%
2019-10-15SaleEagle Pharmaceuticals, Inc.
EGRX
director
3,909
0.0287%
$62.63$244,836-19.71%
2019-10-14PurchaseCantaloupe, Inc.
CTLP
80,000
0.1166%
$6.70$536,024-2.42%
2019-10-11SaleEagle Pharmaceuticals, Inc.
EGRX
director
16,300
0.1192%
$60.39$984,419-16.19%
2019-10-10SaleEagle Pharmaceuticals, Inc.
EGRX
director
7,829
0.0569%
$60.16$471,002-16.16%
2019-10-08SaleEagle Pharmaceuticals, Inc.
EGRX
director
1,558
0.0115%
$60.03$93,520-13.99%
2019-10-07SaleEagle Pharmaceuticals, Inc.
EGRX
director
4,901
0.0358%
$60.11$294,600-15.06%
2019-09-26PurchaseCantaloupe, Inc.
CTLP
605,000
–
$0$0+46.65%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.